Human Gene Therapy - April 2023 - 250
250
IN MEMORIAM
scientist, who also possessed a kind and accommodating
personality as a mentor. We were extremely fortunate to
have met Nick at the very beginning of our scientific
journey in AAV biology and gene therapy. Dr. Chen Ling
completed a laboratory rotation in Professor Muzyczka's
laboratory and later spent 4 years in Professor Srivastava's
laboratory to obtain his PhD degree, with Professor Muzyczka
serving as one of his esteemed doctoral committee
members. Similarly, Dr. Song was fortunate to be a joint
PhD student in Professor Srivastava's laboratory, who
spoke very highly of Nick, which is how our admiration
for him began. Our respect and admiration for Nick continued
to grow as we advanced in our scientific path.
To gene therapy, Nick's laboratory generated the first
AAV plasmid, which has since been used as a common ancestor
construct. To us, Nick and Arun were the very first
vanguardswho ignited our passion forAAVbiology.Wewill
never forget our first encounter with Nick, sitting before him
in his office, eagerly seeking his guidance to understand the
structure of AAV inverted terminal repeats (ITRs), replication
of the AAV genome, and packaging of AAV particles.
We will never forget our first research presentation to Nick,
standing before him in the department lecture hall, seeking
his critique on our studies of the D-sequence of AAV.
We will never forget our first ''Congratulations'' from
Nick, beaming in front of the camera, when we passed our
defense and received our degrees. The very last time we
met Nick in 2022, he was still attentively answering our
scientific questions and offering valuable research advice.
Nick never disappointed us as he was always there to offer
his support during our scientific journey. To us and many
others, his knowledge, expertise, and mentorship not only
established a firm basis for our research, but also profoundly
influenced our career development.
Nick's contribution to the AAV research field was unparalleled.
Nick's passing was a tremendous loss to the scientificcommunityand
toall whohadtheprivilege ofknowing
him. He will be profoundly missed and forever honored as a
true visionary and a pioneering force in the field of AAV
research. May his legacy continue to inspire us in our pursuit
of knowledge and life's work, and may he rest in peace.
Liujiang Song
University ofNorth Carolina/AskBio
and
Chen Ling
Fudan University
I had the pleasure of meeting Nick Muzyczka nearly 43
years ago in early 1980, when I interviewed for a research
associate position in Ken Berns' laboratory at the University
of Florida in Gainesville. My first impression of
Nick was that he was the coolest person I had ever met-
very low-key, down-to-earth, unassuming, and a man of
few words. After I Joined Ken's laboratory in July 1980, I
started interacting with Nick. I even audited a graduate
course in which Nick taught. Ken and Nick began to collaborate
on research on AAV, which resulted in a joint
publication,6 a book chapter,7 and a review article.8
Unfortunately for me (which I realized much later), I left
Ken's laboratory after only 2 years, but I kept in touch with
Human Gene Therapy - April 2023
Table of Contents for the Digital Edition of Human Gene Therapy - April 2023
Contents
Human Gene Therapy - April 2023 - CT1
Human Gene Therapy - April 2023 - CT2
Human Gene Therapy - April 2023 - Cover1
Human Gene Therapy - April 2023 - Cover2
Human Gene Therapy - April 2023 - 239
Human Gene Therapy - April 2023 - 240
Human Gene Therapy - April 2023 - 241
Human Gene Therapy - April 2023 - 242
Human Gene Therapy - April 2023 - 243
Human Gene Therapy - April 2023 - 244
Human Gene Therapy - April 2023 - Contents
Human Gene Therapy - April 2023 - 246
Human Gene Therapy - April 2023 - 247
Human Gene Therapy - April 2023 - 248
Human Gene Therapy - April 2023 - 249
Human Gene Therapy - April 2023 - 250
Human Gene Therapy - April 2023 - 251
Human Gene Therapy - April 2023 - 252
Human Gene Therapy - April 2023 - 253
Human Gene Therapy - April 2023 - 254
Human Gene Therapy - April 2023 - 255
Human Gene Therapy - April 2023 - 256
Human Gene Therapy - April 2023 - 257
Human Gene Therapy - April 2023 - 258
Human Gene Therapy - April 2023 - 259
Human Gene Therapy - April 2023 - 260
Human Gene Therapy - April 2023 - 261
Human Gene Therapy - April 2023 - 262
Human Gene Therapy - April 2023 - 263
Human Gene Therapy - April 2023 - 264
Human Gene Therapy - April 2023 - 265
Human Gene Therapy - April 2023 - 266
Human Gene Therapy - April 2023 - 267
Human Gene Therapy - April 2023 - 268
Human Gene Therapy - April 2023 - 269
Human Gene Therapy - April 2023 - 270
Human Gene Therapy - April 2023 - 271
Human Gene Therapy - April 2023 - 272
Human Gene Therapy - April 2023 - 273
Human Gene Therapy - April 2023 - 274
Human Gene Therapy - April 2023 - 275
Human Gene Therapy - April 2023 - 276
Human Gene Therapy - April 2023 - 277
Human Gene Therapy - April 2023 - 278
Human Gene Therapy - April 2023 - 279
Human Gene Therapy - April 2023 - 280
Human Gene Therapy - April 2023 - 281
Human Gene Therapy - April 2023 - 282
Human Gene Therapy - April 2023 - 283
Human Gene Therapy - April 2023 - 284
Human Gene Therapy - April 2023 - 285
Human Gene Therapy - April 2023 - 286
Human Gene Therapy - April 2023 - 287
Human Gene Therapy - April 2023 - 288
Human Gene Therapy - April 2023 - 289
Human Gene Therapy - April 2023 - 290
Human Gene Therapy - April 2023 - 291
Human Gene Therapy - April 2023 - 292
Human Gene Therapy - April 2023 - 293
Human Gene Therapy - April 2023 - 294
Human Gene Therapy - April 2023 - 295
Human Gene Therapy - April 2023 - 296
Human Gene Therapy - April 2023 - 297
Human Gene Therapy - April 2023 - 298
Human Gene Therapy - April 2023 - 299
Human Gene Therapy - April 2023 - 300
Human Gene Therapy - April 2023 - 301
Human Gene Therapy - April 2023 - 302
Human Gene Therapy - April 2023 - 303
Human Gene Therapy - April 2023 - 304
Human Gene Therapy - April 2023 - 305
Human Gene Therapy - April 2023 - 306
Human Gene Therapy - April 2023 - 307
Human Gene Therapy - April 2023 - 308
Human Gene Therapy - April 2023 - 309
Human Gene Therapy - April 2023 - 310
Human Gene Therapy - April 2023 - 311
Human Gene Therapy - April 2023 - 312
Human Gene Therapy - April 2023 - 313
Human Gene Therapy - April 2023 - 314
Human Gene Therapy - April 2023 - 315
Human Gene Therapy - April 2023 - 316
Human Gene Therapy - April 2023 - 317
Human Gene Therapy - April 2023 - 318
Human Gene Therapy - April 2023 - 319
Human Gene Therapy - April 2023 - 320
Human Gene Therapy - April 2023 - 321
Human Gene Therapy - April 2023 - 322
Human Gene Therapy - April 2023 - 323
Human Gene Therapy - April 2023 - 324
Human Gene Therapy - April 2023 - 325
Human Gene Therapy - April 2023 - 326
Human Gene Therapy - April 2023 - 327
Human Gene Therapy - April 2023 - 328
Human Gene Therapy - April 2023 - 329
Human Gene Therapy - April 2023 - 330
Human Gene Therapy - April 2023 - 331
Human Gene Therapy - April 2023 - 332
Human Gene Therapy - April 2023 - 333
Human Gene Therapy - April 2023 - 334
Human Gene Therapy - April 2023 - 335
Human Gene Therapy - April 2023 - 336
Human Gene Therapy - April 2023 - 337
Human Gene Therapy - April 2023 - 338
Human Gene Therapy - April 2023 - 339
Human Gene Therapy - April 2023 - 340
Human Gene Therapy - April 2023 - 341
Human Gene Therapy - April 2023 - 342
Human Gene Therapy - April 2023 - Cover3
Human Gene Therapy - April 2023 - Cover4
https://www.nxtbookmedia.com